After ISCHEMIA: Is coronary CTA the new gatekeeper?

Smolka, S; Desai, MY; Achenbach, S

Smolka, S (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Dept Cardiol, Ulmenweg 18, D-91054 Erlangen, Germany.

HERZ, 2020; 45 (5): 441

Abstract

The ISCHEMIA trial investigated two major principles in the therapy of coronary artery disease (CAD), i.e., symptom relief and improvement of prognosi......

Full Text Link